Loading...
Structure-guided design of an Hsp90â N-terminal isoform-selective inhibitor
Khandelwal, Anuj Kent, Caitlin N. Balch, Maurie Peng, Shuxia Mishra, Sanket J. Deng, Junpeng Day, Victor W. Liu, Weiya Subramanian, Chitra Cohen, Mark S.
Khandelwal, Anuj
Kent, Caitlin N.
Balch, Maurie
Peng, Shuxia
Mishra, Sanket J.
Deng, Junpeng
Day, Victor W.
Liu, Weiya
Subramanian, Chitra
Cohen, Mark S.
Citations
Altmetric:
Abstract
The 90 kDa heat shock protein (Hsp90) is a molecular chaperone responsible for folding proteins that are directly associated with cancer progression. Consequently, inhibition of the Hsp90 protein folding machinery results in a combinatorial attack on numerous oncogenic pathways. Seventeen small-molecule inhibitors of Hsp90 have entered clinical trials, all of which bind the Hsp90 N-terminus and exhibit pan-inhibitory activity against all four Hsp90 isoforms. pan-Inhibition of Hsp90 appears to be detrimental as toxicities have been reported alongside induction of the pro-survival heat shock response. The development of Hsp90 isoform-selective inhibitors represents an alternative approach towards the treatment of cancer that may limit some of the detriments. Described herein is a structure-based approach to design isoform-selective inhibitors of Hsp90β, which induces the degradation of select Hsp90 clients without concomitant induction of Hsp90 levels. Together, these initial studies support the development of Hsp90β-selective inhibitors as a method to overcome the detriments associated with pan-inhibition.
Description
Date
2018-01-30
Journal Title
Journal ISSN
Volume Title
Publisher
Nature Publishing Group
Collections
Files
Loading...
Khandelwal_2018.pdf
Adobe PDF, 1.32 MB
Research Projects
Organizational Units
Journal Issue
Keywords
Citation
Khandelwal, A., Kent, C. N., Balch, M., Peng, S., Mishra, S. J., Deng, J., ... & Holzbeierlein, J. M. (2018). Structure-guided design of an Hsp90β N-terminal isoform-selective inhibitor. Nature communications, 9(1), 425.